The drug and gene delivery devices market value is projected to grow from USD 410 billion in 2021 and is projected to reach USD 815 billion by 2030; it is expected to grow at a CAGR of 7.2 % from 2021 to 2030.
The report contains 150+ pages with detailed analysis. The market report also covers the estimated market sizes and trends for different countries across major regions, globally.
The global drug and gene delivery devices market is primarily driven by the rising prevalence of various chronic diseases such as cancer, diabetes, and cardiovascular diseases among the global population. The rapid growth of the biopharmaceuticals industry resulted in the development of various therapeutics and gene therapeutics that can effectively treat various chronic diseases and genetic diseases. The rising adoption of such drugs among the population is boosting the growth of the global drug and gene delivery devices market.
Furthermore, the rising investments by the market players in the research and development of the drug delivery systems are fostering the market growth. The technological advancements are providing easy to use and convenient administration of drugs through various roots, which is expected to drive the drug and gene delivery devices market across the globe.
Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1388
Scope of the Drug and Gene Delivery Devices Market
| Report Coverage | Details |
| Market Size in 2021 | USD 410 Billion |
| Growth Rate From 2021 to 2030 | CAGR of 7.2% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Regional Scope |
|
Research Objective
the market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents breakdown of market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2017 to 2020. This research report evaluates drug and gene delivery devices market on a global and regional level. It offers thorough analysis of market status, growth and forecast of the global drug and gene delivery devices market for the period from 2017 to 2030. This research study offers historic data for years 2017 to 2020 along with a forecast from 2021 to 2030 based on value.
This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the drug and gene delivery devices market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Read More@ Automated Parking System Market Value to Boost at 8.9% CAGR through 2030
Asia Pacific is estimated to be the fastest-growing market during the forecast period. The presence of several top biopharmaceutical companies in the nations like India, China, and South Korea is propelling the market growth. The presence of huge population and rising prevalence of chronic diseases among the population is a major factor that is expected to drive the growth of the drug and gene delivery devices market in the region. Furthermore, the rising popularity of the personalized medicines among the population to treat genetic disorder may have a positive impact on the market. The rapid industrialization in the region is resulting in pollution that further propels the number of respiratory diseases among the population. Therefore, the rising number of disease due to the rising pollution levels in the region is expected to offer lucrative growth opportunities to the market players in the upcoming future.
The rising number of approvals for the newly developed therapeutics across the globe is expected to have a positive impact on the market. The major approving authorities such as FDA and EMA are very much active in monitoring the clinical trials of various medicines and diagnostic methods.
The stringent government regulations pertaining the drug and gene delivery devices and the infections and injuries caused by the injectable are the two major restraining factors that may hamper the growth of the global drug and gene delivery devices market during the forecast period.
Based on the delivery type, the injectable is estimated to be the most opportunistic segment during the forecast period. This can be attributed to the development and rising popularity of various injectable such as pen-injectors, self-injectors, and auto-injectors that emerged as a result of the technological advancements in the market. The rising number of diabetic population who needs to inject insulin as a diabetes management measure is expected to drive the growth of this segment. Moreover, the convenience associated with the injectable may boost the adoption of the injectable in the forthcoming years.
Based on the method, the in situ segment dominated the market in 2020. This can be attributed to the certain advantages associated with the in situ method such as low complication in fabrication and ease of drug administration. Moreover, the majority of the drugs that are currently used follows the in situ method.
Based on the vector, the viral vector segment dominated the market in 2020. This is due to the increased usage of the viral vectors for the majority of the clinical trials. Moreover, the rising prevalence of genetic disorders and chronic diseases among the global population is further fueling the segment growth. The extensive use of the viral vectors in the development of drugs and gene therapies has significantly contributed towards the growth of the segment in the past.
The various developmental strategies like acquisitions and mergers foster market growth and offers lucrative growth opportunities to the market players.
Some of the prominent players in the global drug and gene delivery devices market include:
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd
- Johnson and Johnson Private Ltd
- Novartis AG
- Bayer AG
- Becton, Dickinson and Company
- Uniqure NV
Segments Covered in the Report
By Delivery Type
- Oral
- Ocular
- Inhalation
- Nasal
- Injectable
- Transdermal
- Topical
By Method
- In Situ
- Ex Vivo
By Vector
- Viral Vector
- Non-Viral Vector
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
